about
Axonal fluorescence quantitation provides a new approach to assess cutaneous innervation.Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis.Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatusUsefulness of optical coherence tomography to distinguish optic neuritis associated with AQP4 or MOG in neuromyelitis optica spectrum disorders.Current role of chemotherapy and bone marrow transplantation in multiple sclerosis.Structural networks involved in attention and executive functions in multiple sclerosis.Vanishing spinal cord after varicella-zoster virus myelitis.Primary brain lymphomas after kidney transplantation: an under-recognized problem?Impairment of decision-making in multiple sclerosis: A neuroeconomic approach.Liver injury and glatiramer acetate, an uncommon association: case report and literature review.Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates.Motor polyradiculopathy during pembrolizumab treatment of metastatic melanoma.Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes.Visual field impairment captures disease burden in multiple sclerosis.Cognitive functions in multiple sclerosis: impact of gray matter integrity.Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies.Cerebellar ataxia and autoantibodies restricted to glutamic acid decarboxylase 67 (GAD67).Anti-Ma and anti-Ma2-associated paraneoplastic neurological syndromes.Pituitary-ovary axis and ovarian reserve in fertile women with multiple sclerosis: A pilot study.Effects of postural and voluntary muscle contraction on modulation of the soleus H reflex by transcranial magnetic stimulation.Spondylotic myelopathy mimicking myelitis: diagnostic clues by magnetic resonance imaging.Walking function in clinical monitoring of multiple sclerosis by telemedicine.Telemedicine for Monitoring MS Activity and ProgressionIntense immunosuppression for the treatment of an immune reconstitution inflammatory syndrome-like exacerbation after natalizumab withdrawal: a case reportLongitudinally extensive myelitis in a patient with characteristic autoantibody profile of systemic lupus erythematosus: a challenging etiological diagnosisMitochondrial loss indicates early axonal damage in small fiber neuropathiesRebound of multiple sclerosis activity after fingolimod withdrawal due to planning pregnancy: Analysis of predisposing factorsSpanish validation of the telephone assessed Expanded Disability Status Scale and Patient Determined Disease Steps in people with multiple sclerosis
P50
Q33956086-94B53836-2492-4FDE-BE25-F7E4DFC66B15Q34600820-124D3297-5960-4A50-A8CE-0C3161B31D0BQ36827205-12FED028-2866-4E7E-BC7E-B737E59ED5A7Q37197191-67BB8E28-9450-4E75-90A9-F4FC8C99F5F4Q38268313-E8928BA2-65AB-4D5B-9225-8F2319F49906Q40032073-6949981A-F4B3-46C7-88F7-C0DF9B204E38Q40155181-9411A0A7-A9BF-44B4-9560-EA1C79A69A24Q42240667-E2637184-7AC1-4210-95D5-BD4956F31829Q44406117-AAD75418-F50F-4A56-B352-E4745F93183AQ47097362-34FFA7CA-4AF1-401B-B53F-8A3E21E6FC26Q47618323-59EB4046-D96D-45E2-B232-AC71C7DC2D09Q48236699-96E01674-E3C8-4908-A5D3-8E6A8DE0FAEFQ48768047-D9562007-A32A-4A18-B763-8FB70979D568Q48919888-FCDE2ADE-E39F-40E9-AB04-6728A0E6F756Q49075004-2AC64F4F-EF3B-411C-B8FC-1F4210806BCEQ50048448-5A42DC3B-49BF-42D9-9FF8-47F152BA5F97Q50224993-A6885D57-94AC-406D-AE47-99BC0A7B6451Q51615370-9DA38708-F51C-438F-98A4-A5D24E72990FQ52149417-EFED503B-9318-41F1-B4E0-EF047F39E70EQ52151002-0B6104FC-BE1D-4BF6-8673-2556F798A16AQ53265408-3018E20F-552B-41BB-94DF-0492E1E08925Q53512250-EAB507CA-5475-4396-BDD3-733FF38020C7Q57913805-D698A271-15F3-4260-B3F4-CDE25256E8B9Q57913814-225DC224-8B1D-4853-96FE-AD3892C7B08BQ57913816-17BF6E50-1B05-4544-81BC-0B5CBB515745Q57913822-A5393AFF-AD19-4423-9892-3C7FB0658645Q91308511-EFE3948D-59AD-4D74-A397-8AE64588E31DQ93345930-AFFAECA2-F8E1-4C96-88D0-D1625A5B1C90
P50
description
Forscher
@de
chercheur
@fr
hulumtuese
@sq
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Nuria Sola-Valls
@ast
Nuria Sola-Valls
@en
Nuria Sola-Valls
@es
Nuria Sola-Valls
@nl
type
label
Nuria Sola-Valls
@ast
Nuria Sola-Valls
@en
Nuria Sola-Valls
@es
Nuria Sola-Valls
@nl
altLabel
Sola-Valls N
@en
prefLabel
Nuria Sola-Valls
@ast
Nuria Sola-Valls
@en
Nuria Sola-Valls
@es
Nuria Sola-Valls
@nl
P106
P21
P31
P496
0000-0002-6396-219X